Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating)’s stock price rose 6.5% during trading on Wednesday . The stock traded as high as $34.91 and last traded at $34.91. Approximately 1,241,971 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 1,092,597 shares. The stock had previously closed at $32.78. […]
Blair William & Co. IL reduced its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 11.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 15,059 shares of the biotechnology company’s stock after selling 1,870 shares during the period. Blair William & Co. IL’s holdings in Arrowhead Pharmaceuticals were worth $611,000 […]
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) have received a consensus recommendation of “Moderate Buy” from the fifteen brokerages that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price objective […]
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) have been given an average recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average […]
M28 Capital Management LP purchased a new stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 143,900 shares of the biotechnology company’s stock, valued at approximately $5,837,000. Arrowhead Pharmaceuticals makes up […]